DX-103

N/A

Report date: 2024/09/18 10:42:17

Base Information

Drug NameDX-103
Drug Alias NameMydriatic MicroRx
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMydriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesEyenovia Inc
China Registration ClassN/A

Develop Information

Active CompaniesEyenovia Inc
Inactive CompaniesN/A
Active IndicationsMydriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A